Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Prostatic Neoplasms 9Erectile Dysfunction 9Sexuality 2Sexual Dysfunction, Physiological 2Rectal Neoplasms 2Neoplasms 2Fatigue 2Brain Neoplasms 2Waldenstrom Macroglobulinemia 1Vascular Malformations 1Urogenital Neoplasms 1Urinary Bladder Neoplasms 1Solid Tumor 1Sarcoma 1Radiation Injuries 1Pre-Eclampsia 1Postoperative Complications 1Penile Neoplasms 1Pancreatic Neoplasms 1Neurologic Manifestations 1Mental Fatigue 1Lymphoma, Follicular 1Lymphatic Abnormalities 1Lymphangioma 1Infertility 1Glioma 1Glioblastoma 1Gastrointestinal Neoplasms 1Erectile Dysfunction Following Radical Prostatectomy 1Cholangiocarcinoma 1

Interventions

Carboplatin 784Pemetrexed 607Cisplatin 545Paclitaxel 491pembrolizumab 464Docetaxel 440Gemcitabine 328Erlotinib Hydrochloride 307Radiotherapy 258Nivolumab 244Bevacizumab 233osimertinib 178Drug Therapy 164durvalumab 157atezolizumab 135Gefitinib 134Radiosurgery 133Vinorelbine 111Cetuximab 97130-nm albumin-bound paclitaxel 94Ipilimumab 86Magnetic Resonance Spectroscopy 84Taxes 79Surgical Procedures, Operative 74Afatinib 68Albumin-Bound Paclitaxel 66Specimen Handling 61Etoposide 61Cyclophosphamide 60tislelizumab 59

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Non-Small-Cell Lung × Sildenafil Citrate × Clear all
NCT00752115 2011-09-07

Combination Chemotherapy With Sildenafil Plus Carboplatin and Paclitaxel in Patients With Advanced Non-small Cell Lung Cancer

Hamamatsu University

Phase 2/3 Completed
120 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡